{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:17Z","timestamp":1781308697418,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NCT05084508"],"award-info":[{"award-number":["NCT05084508"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128439","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:41:15Z","timestamp":1773355275000},"page":"128439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12\u201315\u00a0months: results of a phase II, controlled, randomized trial"],"prefix":"10.1016","volume":"79","author":[{"given":"Md Ahsan","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Domachowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Senders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Korbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata D.","family":"Gassama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Debrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Benedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Povey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airi","family":"P\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128439_bb0005","author":"Lopez"},{"key":"10.1016\/j.vaccine.2026.128439_bb0010","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/molecules26041132","article-title":"Advances and perspectives in the Management of Varicella-Zoster Virus Infections","volume":"26","author":"Andrei","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2026.128439_bb0015","author":"European Center for Disease Prevention and Control"},{"key":"10.1016\/j.vaccine.2026.128439_bb0020","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","article-title":"Varicella in Europe\u2014a review of the epidemiology and experience with vaccination","volume":"33","author":"Helmuth","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128439_bb0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.vaccine.2022.12.011","article-title":"Prospective study of loss of health-related quality adjusted life years in children and their families due to uncomplicated and hospitalised varicella","volume":"41","author":"Rodrigues","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128439_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2266225","article-title":"Healthcare resource use and costs of varicella and its complications: a systematic literature review","volume":"19","author":"Williame","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128439_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40121-023-00899-7","article-title":"Global prevalence of varicella-associated complications: a systematic review and Meta-analysis","volume":"13","author":"Shah","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128439_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14737167.2024.2410257","article-title":"Estimated value of productivity lost due to childhood chickenpox in the United Kingdom: a survey of parents","volume":"25","author":"Wittenberg","year":"2025","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.vaccine.2026.128439_bb0045","first-page":"567","article-title":"WHO position paper on varicella vaccines \u2013 November 2025","volume":"100","author":"World Health Organization","year":"2025","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.128439_bb0050","article-title":"Clinical efficacy and effectiveness of alternative varicella vaccination strategies: an overview of reviews","volume":"33","author":"Ahern","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2026.128439_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.2013-4251","article-title":"Impact of vaccination on the epidemiology of varicella: 1995-2009","volume":"134","author":"Baxter","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.128439_bb0060","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.128439_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2024-327593","article-title":"Varicella: is it time for a global vaccination programme?","author":"Wooding","year":"2025","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2026.128439_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group a streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2026.128439_bb0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128439_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3345\/cep.2021.01564","article-title":"Global varicella vaccination programs","volume":"65","author":"Lee","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.vaccine.2026.128439_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128072-200103040-00005","article-title":"25 years\u2019 experience with the Biken Oka strain varicella vaccine","volume":"3","author":"Takahashi","year":"2001","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.vaccine.2026.128439_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128439_bb0095","series-title":"Requirements for varicella vaccine (live)","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128439_bb0100","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128439_bb0105","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.vaccine.2020.03.009","article-title":"Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children","volume":"38","author":"Feyssaguet","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128439_bb0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128439_bb0115","series-title":"Child and Adolescent Immunization Schedule by Age","author":"U.S. Centers for Disease Control and Prevention","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128439_bb0120","author":"European Center for Disease Prevention and Control"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:53:36Z","timestamp":1781308416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"alternative-id":["S0264410X26002471"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128439","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12\u201315\u00a0months: results of a phase II, controlled, randomized trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 GSK Plc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128439"}}